Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 103

    Indoco Remedies gets USFDA warning letter for significant violations at Goa facility

    Indoco Remedies gets USFDA warning letter for significant violations at Goa facility

    Medical Dialogues Bureau26 July 2019 9:30 AM IST
    Stating the specific violations, the US Food and Drug Administration (USFDA) said Indoco Remedies failed to prepare batch production and control...
    Allergan announces worldwide recall of textured breast implant tied to rare cancer

    Allergan announces worldwide recall of textured breast implant tied to rare cancer

    Medical Dialogues Bureau26 July 2019 9:15 AM IST
    The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan Inc's Biocell breast implants account for a...
    Pharma lobby group opposes senators proposal to lower drug prices: Report

    Pharma lobby group opposes senators' proposal to lower drug prices: Report

    Farhat Nasim26 July 2019 9:00 AM IST
    The proposal aims to lower drug prices by forcing pharmaceutical companies to pay rebates to Medicare if they raise prices above the rate of...
    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Zydus Cadila launches Ramelteon tablets in US to treat insomnia

    Medical Dialogues Bureau25 July 2019 11:23 AM IST
    In a BSE filing, Zydus Cadila announced the "launch of Ramelteon tablets, 8 mg upon receiving the final approval from the USFDA. Ramelteon is a...
    Manipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of Stempeucel

    Manipal Group Stempeutics, Kemwell strike deal worth Rs 95 crore for global commercialisation of Stempeucel

    Medical Dialogues Bureau25 July 2019 9:45 AM IST
    The funds will be utilized for achieving key regulatory milestones in the US, Europe and Japan, and for establishing a cGMP cell therapy manufacturing...
    Syngene International Q1 net profit rises 9 percent to Rs 72 crore

    Syngene International Q1 net profit rises 9 percent to Rs 72 crore

    Medical Dialogues Bureau25 July 2019 9:30 AM IST
    The company had posted a net profit of Rs 66.2 crore for the same period previous fiscal, Syngene International said in a BSE filing.New Delhi:...
    Merck biosimilar to AbbVie blockbuster Humira wins USFDA approval

    Merck biosimilar to AbbVie blockbuster Humira wins USFDA approval

    Medical Dialogues Bureau25 July 2019 9:00 AM IST
    Humira is the world's best-selling prescription medicine and in the six years since AbbVie spun out from device maker Abbott Labs, the drug has...
    Pfizer gets USFDA nod for biosimilar to Rituximab

    Pfizer gets USFDA nod for biosimilar to Rituximab

    Medical Dialogues Bureau25 July 2019 8:59 AM IST
    Ruxience is a mAb biosimilar to Rituxan which works by targeting a protein called CD20, which is present on the surface of B cells. Ruxience is...
    Alembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic control

    Alembic Pharma gets tentative USFDA nod for Dapagliflozin Tablets to improve glycemic control

    Medical Dialogues Bureau24 July 2019 10:00 AM IST
    The approved Dapagliflozin Tablets is therapeutically equivalent to the reference listed drug product Farxiga Tablets of AstraZeneca AB.New Delhi:...
    Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia

    Dr Reddys unveils generic version of Rozerem Tablets in US for treating insomnia

    Farhat Nasim24 July 2019 9:35 AM IST
    The product is a therapeutically equivalent generic version of Rozerem (ramelteon, 8 mg) Tablets, approved by the U.S. Food and Drug Administration...
    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Medical Dialogues Bureau24 July 2019 9:30 AM IST
    The firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
    Sanofi strikes deal for US rights to Roche Tamiflu

    Sanofi strikes deal for US rights to Roche Tamiflu

    Medical Dialogues Bureau24 July 2019 9:15 AM IST
    Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
    PrevNext

    Popular Stories

    CDSCO flags 34 drugs for failing quality test; Details

    CDSCO flags 34 drugs for failing quality test; Details

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    No discussion on alleged bribes given by pharma firms to doctors at PM Modis meet, claims IPA

    No discussion on alleged bribes given by pharma firms to doctors at PM Modi's meet, claims IPA

    China offers tariff exemptions on US medical equipment amid virus outbreak

    China offers tariff exemptions on US medical equipment amid virus outbreak

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    HDFC gets CCI nod for buying 51.2 pc stake in Apollo Munich Health for Rs 1347 crore

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok